Selection Process & Jury
At the beginning of each award cycle, Harold Hamm representatives will select a jury of five international leaders in the field of diabetes research to nominate and select the Prize Laureate. In their consideration of Nominees, Selection Jury members will write a Nominating Statement for two Nominees. Jurors can either select their own Nominees or, at their discretion, chose Nominees recommended by the diabetes community at large through an open call for Letters of Recommendation. Any person writing a Letter of Recommendation must submit his or her letter prior to the public announcement of the Selection Jury (for the 2013 awarding of the Prize, the deadline was October 31, 2012). Details for submitting a Letter of Recommendation
Once Nominees are selected, Jurors will deliberate at Harold Hamm Diabetes Center in Oklahoma City. Deliberations will begin with each Juror presenting the merits of his/her two Nominees. After ensuing discussion, the voting process will begin. The Prize Laureate will be selected through a process of eliminative voting; this is a process of successive rounds, in each of which the Nominee receiving the lowest number of votes is eliminated. Eventually, one Nominee will remain, and will be declared the Prize Laureate. In this process, Jurors vote for individual nominees, rather than against them.
No administrative or research officer from Harold Hamm casts a vote in the final voting procedure.
Members of the 2013 Jury
John Buse, MD, PhD, CDE -- Dr. Buse received his MD and PhD from Duke University in Durham, North Carolina before training in internal medicine and endocrinology at the University of Chicago. He is currently a professor at the University of North Carolina (UNC) School of Medicine in Chapel Hill, North Carolina where he also serves as the Chief of the Division of Endocrinology, Director of the Diabetes Care Center and Executive Associate Dean for Clinical Research.
Edwin Gale, MD -- Prof Gale is Emeritus Professor of Diabetic Medicine and former Head of the University Department of Clinical Science in North Bristol. His major research interests have been in the pathogenesis of type 1 diabetes, but he has written reviews and opinion pieces on many aspects of diabetes, and was Editor of Diabetologia from 2003-2010. He has chaired the Special Advisory Group on diabetes and endocrinology for the European Medicines Agency (EMA) for the past 5 years. He is currently engaged in setting up Diapedia, an online open-access living textbook of diabetes.
Barbara Howard, PhD -- Dr. Howard is the Senior Scientist and former president of MedStar Health Research Institute. She received her PhD in Microbiology from the University of Pennsylvania and currently holds a faculty appointment in the Department of Medicine at Georgetown University. Dr. Howard serves on several Data Safety Monitoring Boards for federal studies and on the editorial boards of numerous scientific journals. She has chaired the Nutrition Committee and The Council on Nutrition Physical Activity and Metabolism of the American Heart Association. Dr. Howard also chaired the Nutrition Study Section of the National Institutes of Health and served as a member of the NTH Expert Panel on Obesity that developed guidelines for the treatment and prevention of obesity.
Paul Robertson, MD -- Dr. Robertson received his MD from Creighton Medical School before training in endocrinology at the University of Washington, where he is currently a Professor of Medicine and Pharmacology. Dr. Robertson has served as the American Diabetes Association President for Medicine and Science; Editor-in-Chief of Translations in Endocrinology and Metabolism, Endocrine Reviews, and Diabetes.
Charles Stanley, MD -- Dr. Stanley is the medical director of the Congenital Hyperinsulinism Center at The Children's Hospital of Philadelphia and a professor emeritus of pediatrics at the Perelman School of Medicine at the University of Pennsylvania. He has published numerous articles in journals such as The New England Journal of Medicine, Journal of Pediatrics, Diabetes, Journal of Clinical Endocrinology and Metabolism, and The Journal of Biological Chemisty. He was recently co-editor of Monogenic Hyperinsulinemic Hypoglycemia Disorders, volume 21 of "Frontiers in Diabetes."